ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,740.47
0.02%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. AQSE
  6. HUTCHMED China Limited (HCM.GB)

  7. HUTCHMED China Limited (HCM.GB) News

HUTCHMED China (HCM.GB)

HUTCHMED China Limited
Date:
Sort by:
 Showing the most relevant articles for your search:AQSE:HCM.GB
DateTimeSourceHeadlineSymbolCompany
29/12/202308:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
29/12/202308:30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnAQSE:HCM.GBHUTCHMED China Limited
21/12/202310:00UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementAQSE:HCM.GBHUTCHMED China Limited
07/12/202310:04UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementAQSE:HCM.GBHUTCHMED China Limited
30/11/202308:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
09/11/202307:00UK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)AQSE:HCM.GBHUTCHMED China Limited
24/10/202309:30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPAQSE:HCM.GBHUTCHMED China Limited
29/09/202309:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
14/09/202309:30UK RegulatoryHutchmed (China) Limited Director's Share DealingAQSE:HCM.GBHUTCHMED China Limited
31/08/202309:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
21/08/202307:00UK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointAQSE:HCM.GBHUTCHMED China Limited
07/08/202309:30UK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorAQSE:HCM.GBHUTCHMED China Limited
31/07/202312:00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesAQSE:HCM.GBHUTCHMED China Limited
13/07/202309:30UK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeAQSE:HCM.GBHUTCHMED China Limited
29/06/202309:30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnAQSE:HCM.GBHUTCHMED China Limited
26/06/202309:30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsAQSE:HCM.GBHUTCHMED China Limited
16/06/202307:00UK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetAQSE:HCM.GBHUTCHMED China Limited
15/06/202315:39UK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMAAQSE:HCM.GBHUTCHMED China Limited
06/06/202310:00UK RegulatoryHutchmed (China) Limited LTIP and Share Option SchemeAQSE:HCM.GBHUTCHMED China Limited
31/05/202309:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
26/05/202307:00UK RegulatoryHutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDAAQSE:HCM.GBHUTCHMED China Limited
17/05/202309:30UK RegulatoryHutchmed (China) Limited Standard form for notification of major holdingsAQSE:HCM.GBHUTCHMED China Limited
12/05/202313:15UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsAQSE:HCM.GBHUTCHMED China Limited
12/05/202309:30UK RegulatoryHutchmed (China) Limited Board of Directors and Board Committee MembershipAQSE:HCM.GBHUTCHMED China Limited
10/05/202309:30UK RegulatoryHutchmed (China) Limited Appointment of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
28/04/202309:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
21/04/202309:30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPAQSE:HCM.GBHUTCHMED China Limited
11/04/202309:30UK RegulatoryHutchmed (China) Limited 2022 Annual Report and Notice of AGMAQSE:HCM.GBHUTCHMED China Limited
11/04/202309:30UK RegulatoryHutchmed (China) Limited Intended Retirement of Independent NEDAQSE:HCM.GBHUTCHMED China Limited
31/03/202309:30UK RegulatoryHutchmed (China) Limited Total Voting RightsAQSE:HCM.GBHUTCHMED China Limited
 Showing the most relevant articles for your search:AQSE:HCM.GB

Your Recent History

NASDAQ
AAWRDXX
Morgan Stanley Finance L...
NASDAQ
AAYBZXX
Jpmorgan Chase Financial...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved